Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Heather Hathorne
Director-Clinical Research Administration
Close
E-mail
hhathorne@uab.edu
Visualizations
Co-investigator Network
Heather Hathorne
Director-Clinical Research Administration
Positions
Associate Scientist (C)
,
Cystic Fibrosis Research Center
,
School of Medicine
Assistant Professor (P)
,
Respiratory Therapy Program
,
Clinical & Diagnostic Sciences
Research
Background
Contact
Research
Principal Investigator On
Success with Therapies Research Consortium
awarded by
Cystic Fibrosis Foundation ^
Investigator On
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are Colonized with Nontuberculous Mycobacteria (The ABATE Study)
awarded by
SEATTLE CHILDREN'S HOSPITAL
A Pilot Study of the Effect of the CFTR Potentiator Ivacaftor in COPD (P-Topic)
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study) (PROMISE-OB-18)
awarded by
Cystic Fibrosis Foundation ^
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
awarded by
Cystic Fibrosis Foundation ^
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis (PROSPECT) ("Clinical Study")
awarded by
SEATTLE CHILDREN'S HOSPITAL
An Open Label N of 1 Study to Evaluate the Safety and Efficacy of Long-Term Treatment with Ivacaftor in Combination with ALTALUREN (PTCD124) In Subjects with Nonsense Mutation Cystic Fibrosis
awarded by
University of Pennsylvania
Assessing Response of B-Adrenergic Sweat Secretion in Patients with R117H Mutations Following Treatment with Ivacaftor (GOALe2 Ancillary)
awarded by
Cystic Fibrosis Foundation ^
Baby Observational and Nutritional Study (BONUS-IP-11)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Bronchiectasis Research Registry
awarded by
COPD FOUNDATION
Characterizing CFTR Modulated Changes in Sweat Chloride & Clinical Outcomes
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Development of Standardized Measures of Barriers to Treatment Adherence: Field Testing and Psychometric Validation
awarded by
CHILDREN'S HOSPITAL (BOSTON)
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
G551D Observational Study (GOAL-OB-11)
awarded by
Cystic Fibrosis Foundation ^
G551D Observational Study-Expanded to Additional Genotypes and Extended for Long Term Follow-Up (GOAL-e2)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
G551D Observational Study-SEATTLE GOAL
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma
awarded by
American Lung Association
Losartan as Anti-Inflammatory Therapy to Augment F508del CFTR Recovery
awarded by
University of Miami
MDA MOVR Data Hub
awarded by
Muscular Dystrophy Association
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
PCD Foundation (PCDF) Registry: A Longitudinal Study of Patients with Primary Ciliary Dyskinesia
awarded by
THE PCD/KS FOUNDATION DBA PCD FOUNDATION
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Prevalence and Significance of Staphylococcus Aureus Small–Colony Variants
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
FOREST LABORATORIES, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
SYNEDGEN, INC
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
Gilead Sciences ^
Private Grant
awarded by
NIVALIS THERAPEUTICS, INC. - NEW
Private Grant
awarded by
N30 PHARMACEUTICALS, LLC
Private Grant
awarded by
Teva Pharmaceuticals
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
GlaxoSmithKline
Private Grant
awarded by
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Private Grant
awarded by
GALAPAGOS NV.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PTC THERAPEUTICS, INC.
Private Grant
awarded by
PTC THERAPEUTICS, INC.
Private Grant
awarded by
NIVALIS THERAPEUTICS, INC. - NEW
Private Grant
awarded by
JAZZ PHARMACEUTICALS, INC.
Private Grant
awarded by
Bayer HealthCare
Private Grant
awarded by
Bayer AG
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
NIVALIS THERAPEUTICS, INC. - NEW
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROQR THERAPEUTICS
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROQR THERAPEUTICS
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
CELTAXSYS, INC.
Private Grant
awarded by
NIVALIS THERAPEUTICS, INC. - NEW
Private Grant
awarded by
PTC THERAPEUTICS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PTC THERAPEUTICS, INC.
Private Grant
awarded by
PARION SCIENCES, INC.
Private Grant
awarded by
Gilead Sciences ^
Private Grant
awarded by
SANTHERA PHARMACEUTICALS LIMITED (SWITZERLAND)
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
ASTRAZENECA AB
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
ASTRAZENECA AB
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROTEOSTASIS THERAPEUTICS, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
TRANSLATE BIO, INC ^
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
PROTEOSTASIS THERAPEUTICS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
SANTHERA PHARMACEUTICALS LIMITED (SWITZERLAND)
Private Grant
awarded by
TRANSLATE BIO, INC ^
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
ELECTROMED, INC.
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
TRANSLATE BIO, INC ^
Private Grant
awarded by
ASTRAZENECA PHARMACEUTICALS LP
Private Grant
awarded by
PARATEK PHARMACEUTICALS, LLC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
BIOMX INC
Private Grant
awarded by
4D MOLECULAR THERAPEUTICS INC
Private Grant
awarded by
INSMED PHARMACEUTICALS, INC.
Private Grant
awarded by
AN2 THERAPEUTICS
Private Grant
awarded by
VERTEX PHARMACEUTICALS, INC.
Private Grant
awarded by
RENOVION, INC.
Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S HOSPITAL
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
awarded by
SEATTLE CHILDREN'S HOSPITAL
Rare CFTR Mutation Cell Collection Protocol (RARE)
awarded by
SEATTLE CHILDREN'S HOSPITAL
Rare Mutations in Cystic Fibrosis: Overcoming Barriers to Personalized Medicine
awarded by
Emory University
Saline Hypertonic in Preschoolers (SHIP)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Standardized Treatment of Pulmonary Exacerbations II
awarded by
SEATTLE CHILDREN'S HOSPITAL
Standardizing Treatments for Pulmonary Exacerbations: A Platform for Evaluating Treatment Decisions to Improve Outcomes (STOP360)
awarded by
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Success with Therapies Research Consortium
awarded by
Cystic Fibrosis Foundation ^
TRI-STAR Initial and Chronic MRSA Infection in CF
awarded by
University of North Carolina at Chapel Hill
The 2015 TDN Spring Meeting
awarded by
Cystic Fibrosis Foundation ^
Therapeutic Development Center - UAB Center for CFTR Detection
awarded by
Cystic Fibrosis Foundation ^
Therapeutics Development Center Award
awarded by
Cystic Fibrosis Foundation ^
Therapeutics Development Center Award
awarded by
Cystic Fibrosis Foundation ^
Training and Equipment for the MBW sub-study of the PROSPECT Study.
awarded by
Cystic Fibrosis Foundation ^
Translational Program in CFTR-Related Airway Diseases
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
UAB Cystic Fibrosis Therapeutic Development Network Center for CFTR Detection
awarded by
Cystic Fibrosis Foundation ^
UAB Cystic Fibrosis Translational Development Center
awarded by
Cystic Fibrosis Foundation ^
UAB Therapeutic Development Network Center
awarded by
Cystic Fibrosis Foundation ^
Background
Education And Training
Doctor of Philosophy in Public Health Education and Promotion,
University of Alabama at Birmingham
2015
Master of Education in Health and Physical Education / Fitness,
University of Alabama at Birmingham
2005
Bachelor of Science or Mathematics in Respiratory Care Therapy / Therapist,
University of Alabama at Birmingham
2000
Contact
Full Name
Heather
Hathorne